Robuta

https://www.techtransfer.nih.gov/patent/e-099-2014-0-jp-13 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | Technology Transfer mesothelintargetedchimericantigenreceptors https://www.techtransfer.nih.gov/patent/e-117-2011-0-ru-16 Recombinant Immunotoxin Targeting Mesothelin | Technology Transfer recombinanttargetingmesothelintechnologytransfer https://www.techtransfer.nih.gov/patent/e-198-2012-0-us-06 Mesothelin Domain-Specific Monoclonal Antibodies and Use Thereof | Technology Transfer domain specificmonoclonal antibodiesmesothelinusetechnology https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01263/full Frontiers | Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian... Ovarian malignancies remain the leading cause of death in female gynecological tumors. More than 70% patients are diagnosed with advanced stage with extensiv... https://www.techtransfer.nih.gov/patent/e-094-2017-0-jp-08 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment | Technology... human antibody https://www.techtransfer.nih.gov/patent/e-099-2014-0-jp-10 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | Technology Transfer mesothelintargetedchimericantigenreceptors https://www.techtransfer.nih.gov/patent/e-117-2011-0-ma-32 Recombinant Immunotoxin Targeting Mesothelin | Technology Transfer recombinanttargetingmesothelintechnologytransfer https://www.techtransfer.nih.gov/patent/e-078-2012-0-us-01 Anti-Mesothelin Chimeric Antigen Receptors | Technology Transfer antimesothelinchimericreceptorstechnology https://scholars.lib.ntu.edu.tw/entities/publication/5fabfff7-c680-4487-b24b-58e36256bcf8 Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific... As a tumor antigen, mesothelin (MSLN) can be identified in various malignancies. MSLN is potential for antigen-specific cancer vaccines. We generated a novel... https://edrn.cancer.gov/data-and-resources/publications/22155417-2231-evaluation-of-ovarian-cancer-remission-markers-he4-mmp7-and-mesothelin-by-comparison-to-the-established-marker-ca125/ Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the... This is a publication by a member of the Early Detection Research Network. https://researchfestival.nih.gov/2015/posters/new-high-affinity-monoclonal-antibodies-recognize-non-overlapping-epitopes New High Affinity Monoclonal Antibodies Recognize Non-Overlapping Epitopes On Mesothelin For... new highmonoclonal antibodies https://www.techtransfer.nih.gov/patent/e-118-2013-0-pct-02 Mesothelin-Specific Immunocytokine And Use Thereof | Technology Transfer mesothelinspecificusetechnologytransfer https://www.techtransfer.nih.gov/patent/e-236-2012-0-pct-02 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY | Technology Transfer mesothelinantibodiesmethods https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1268927/full Frontiers | Mesothelin expression remodeled the immune-matrix tumor microenvironment predicting the... The combination of immunobiological agents with immune checkpoint proteins is a promising treatment for malignant pleural mesothelioma (MPM). Mesothelin and ... tumor microenvironmentfrontiersmesothelinexpressionremodeled https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2019-05711&r=1 Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression - NCI Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression in patients https://www.techtransfer.nih.gov/patent/e-040-2019-0-us-07 Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors | Technology... single domain antibodiescross species https://edrn.cancer.gov/data-and-resources/miscellaneous-resources/hgnc-entry-for-human-mesothelin-msln/ HGNC entry for human mesothelin MSLN This is a miscellaneous resource located at https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7371 for humanhgncentrymesothelin https://pubmed.ncbi.nlm.nih.gov/22412141/ Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data... In patients suspected of having mesothelioma, a positive blood test for mesothelin at a high-specificity threshold is a strong incentive to urge further... pleural mesotheliomaan individualserummesothelindiagnosing https://hspop.uw.edu/publication/effects-of-personal-characteristics-on-serum-ca125-mesothelin-and-he4-levels-in-healthy-postmenopausal-women-at-high-risk-for-ovarian-cancer/ Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy... Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh M, Andersen MR, Scholler N, Bergan L, Thorpe J, Urban N, Drescher CW. Effects of personal... https://www.techtransfer.nih.gov/patent/e-015-2005-0-pct-02 Anti-Mesothelin Antibodies Useful for Immunological Assays | Technology Transfer useful forantimesothelinimmunologicalassays https://www.techtransfer.nih.gov/patent/e-015-2005-0-ca-04 Anti-Mesothelin Antibodies Useful for Immunological Assays | Technology Transfer useful forantimesothelinimmunologicalassays https://www.techtransfer.nih.gov/patent/e-120-2007-0-us-01 Mesothelin Expression In Human Lung Cancer | Technology Transfer in humanlung cancermesothelinexpressiontechnology https://www.sciencedaily.com/releases/2008/02/080215082748.htm Mesothelin Engineered On Virus-like Particles Provides Treatment Clues For Pancreatic Cancer |... New understanding of a protein that spurs the growth of pancreatic cancer could lead to a new vaccine against the deadly disease. The protein called mesothelin... https://www.techtransfer.nih.gov/patent/e-091-2009-0-us-01 Human Monoclonal Antibody Variable Fragments (Fvs) To Mesothelin | Technology Transfer human monoclonalantibodyvariablefragmentsfvs https://www.techtransfer.nih.gov/patent/e-078-2012-0-fr-12 Anti-Mesothelin Chimeric Antigen Receptors | Technology Transfer antimesothelinchimericreceptorstechnology https://pmc.ncbi.nlm.nih.gov/articles/PMC11874698/ Mesothelin-targeted CAR-T cells secreting NKG2D-BiTEs exhibit potent efficacy against... Triple-negative breast cancer (TNBC) is an aggressive subtype with poor prognosis and limited treatment options. Chimeric antigen receptor (CAR)-T cell therapy... car t cells https://www.techtransfer.nih.gov/patent/e-117-2011-0-br-04 Recombinant Immunotoxin Targeting Mesothelin | Technology Transfer recombinanttargetingmesothelintechnologytransfer https://pubmed.ncbi.nlm.nih.gov/37040900/ High mesothelin expression by immunohistochemistry predicts improved survival in pleural... MSLN expression was more heterogenous in epithelioid mesothelioma than reported previously. Therefore, it would be appropriate to perform an... highmesothelinexpressionimmunohistochemistrypredicts https://www.techtransfer.nih.gov/patent/e-079-2008-0-au-03 Human Anti-Mesothelin Monoclonal Antibodies | Technology Transfer monoclonal antibodieshumanmesothelintechnologytransfer https://scholars.duke.edu/publication/1474944 Scholars@Duke publication: Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients... https://www.techtransfer.nih.gov/patent/e-099-2014-0-fr-20 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | Technology Transfer mesothelintargetedchimericantigenreceptors https://www.techtransfer.nih.gov/patent/e-002-1996-1-jp-13 MESOTHELIN ANTIGEN AND METHODS AND KITS FOR TARGETING IT | Technology Transfer it technologymesothelinantigenmethodskits https://www.businesswire.com/news/home/20230314005352/en/Eureka-Therapeutics-Licenses-Promising-Antibody-Targeting-Mesothelin-from-the-National-Cancer-Institute Eureka Therapeutics Licenses Promising Antibody Targeting Mesothelin from the National Cancer... Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies to treat cancer, today announced it has entered into a li... from theeurekatherapeuticslicensespromising https://research.monash.edu/en/publications/preclinical-efficacy-of-an-antibody-drug-conjugate-targeting-meso/ Preclinical efficacy of an antibody-drug conjugate targeting mesothelin correlates with... preclinicalefficacyantibody https://pubmed.ncbi.nlm.nih.gov/32517181/ From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic... Pancreatic ductal adenocarcinoma (PDAC), accounting for 90% of all pancreatic tumors, is a highly devastating disease with poor prognosis and rising incidence.... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1060905/full Frontiers | A tri-specific killer engager against mesothelin targets NK cells towards lung cancer New treatments are required to enhance current therapies for lung cancer. Mesothelin is a surface protein overexpressed in non-small cell lung cancer (NSCLC)...